Biotech
-
268Vodis Pharmaceuticals Inc (CNSX:VP): Weak Underlying Fundamentals Spell Trouble Despite Rally
Trading activity around Vodis Pharmaceuticals Inc. (CNSX:VP) stock has picked up the pace, depicted by high turnover in traded shares. However, a 100%...
-
591Scythian Biosciences Corp (CNSX:SCYB) Focused On Venturing Into the U.S. Market
The year has been a roller coaster for Scythian Biosciences Corp (CNSX:SCYB). Generally, the company has experienced one of its longest bear...
-
321Earth Science Tech Inc (OTCMKTS:ETST) Gets A $3.60 Price Target
Earth Science Tech Inc (OTCMKTS:ETST) is showing signs of trading higher following a string of positive developments that have renewed investor interest...
-
8421Vivos Inc (OTCMKTS:RDGL) Surging After Sarcoma Treatment Breakthrough And Toxic Debt Elimination
Vivos Inc. (OTCMKTS:RDGL) has received a lifeline, after coming under immense selling pressure. A plunge below the $0.01 mark had raised serious...
-
711Cure Pharmaceutical Holding Corp (OTCMKTS:CURR) Surging on Canopy Growth Corp (NYSE: CGC) Licensing Deal
Cure Pharmaceutical Holding Corp (OTCMKTS:CURR) is back to winning ways, on bulls regaining control after bears threatened to plunge the stock to...
-
1.8KFSD Pharma Inc (OTCMKTS:FSDDF) Is Skyrocketing
FSD Pharma Inc (OTCMKTS:FSDDF) exploded in the market on announcing positive pre-clinical results for a proprietary CBD combination product. The upward momentum...
-
384Sunshine Biopharma, Inc. (OTCMKTS:SBFM) Is A Sell As Short Sellers Remain In Firm Control
A bear run that has engulfed Sunshine Biopharma, Inc. (OTCMKTS:SBFM) since the start of the year is still in play, despite the...
-
1.8KPropanc Biopharma Inc (OTCMKTS:PPCB) Surging On Two Key Cancer Patents
Propanc Biopharma Inc (OTCMKTS:PPCB) stock has bounced back to life on news the company has entered a national phase on two key...
-
5331Biotricity Inc (OTCMKTS:BTCY) Surging On Investors Taking Note of Remote Monitoring Opportunity
Biotricity Inc (OTCMKTS:BTCY) has bottomed out from two years lows, having felt the wrath of short sellers. After shedding more than 80%...
